2025
November 24, 2025
Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
November 20, 2025
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
November 10, 2025
EXACT SCIENCES ANNOUNCES EXPIRATION OF THE HSR WAITING PERIOD FOR EXCLUSIVE LICENSE TO FREENOME’S BLOOD-BASED COLORECTAL CANCER SCREENING TESTS
November 10, 2025
Exact Sciences Announces Expiration Of The HSR Waiting Period For Exclusive License To Freenome’s Blood-Based Colorectal Cancer Screening Tests
November 3, 2025
Exact Sciences Announces Third Quarter 2025 Results
October 27, 2025
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
October 27, 2025
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
September 22, 2025
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test
September 17, 2025
Exact Sciences Launches the OncodetectTM Molecular Residual Disease Test
September 17, 2025
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
September 17, 2025
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard PlusTM Test Cologuard PlusTM Available In-Network August 2025
September 17, 2025
Cologuard Included in American Cancer Society Colorectal Cancer Prevention and Early Detection Guidelines
September 10, 2025
Exact Sciences Launches CancerguardTM, First-of-Its-Kind Multi-Cancer Early Detection Blood Test
August 6, 2025
Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening tests
August 6, 2025
Exact Sciences Announces Second Quarter 2025 Results
June 27, 2025
Meet the people behind Cologuard: #TeamCologuard
June 27, 2025
EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH
June 27, 2025
Exact Sciences Laboratories Hits High Gear
June 27, 2025
Giving Thanks to Madison this Season
June 27, 2025
Exact Sciences Announces Final Payment Decision for Cologuard® from the Centers for Medicare & Medicaid Services
June 27, 2025
Exact Sciences Announces Cologuard Will Now Be Available By Prescription Through MDVIP Physicians
June 27, 2025
CEO Kevin Conroy Presents Cologuard Commercial Launch Update at 2014 Baird Healthcare Conference
June 27, 2025
Cologuard® in the News: Week Three
June 27, 2025
Cologuard® in the News: Week Two
June 27, 2025
Cologuard in the News: Week One
June 27, 2025
WEO: A More Accessible Colorectal Cancer Screening Test Is Key For Increasing Participation
June 27, 2025
Quality Measures For Colon Cancer Screening Should Not Focus On Age Alone, Study Suggests
June 27, 2025
Rare Disease Day: 4 Things to Know
June 27, 2025
A 12-Step Winter Workout You Can Do at Home
June 27, 2025
CRC News Round-up: Surgeon General Links Cigarette Smoking and Colorectal Cancer for the First Time
June 27, 2025
2013 Hero Of The Month Highlights
June 27, 2025
Healthy Living Recipe: Beans, Greens & Quinoa Soup
June 27, 2025
Exact Sciences Reports On Q3 Earnings
June 27, 2025
Healthy Living: Climbing to Stay Fit
June 27, 2025
September's Hero of the Month: Colon Cancer Prevention Project Executive Director Andrea Shepherd
June 27, 2025
Staying Active: A Family Effort
June 27, 2025
Weekly cooking inspiration: Our CSA Surprise!
June 27, 2025
Living with Crohn’s Disease
June 27, 2025
August Hero of the Month: Colon Cancer Survivor and WunderGlo Foundation Founder Gloria Borges
June 27, 2025
Climbing The Mountain
June 27, 2025
DeeP-C Clinical Trial Preliminary Top-Line Results
June 27, 2025
The DeeP-C Clinical Trial: A Physician's Perspective
June 27, 2025
From Blue Star Pins to Blue Hair: How Exact Sciences Participated in Colon Cancer Awareness Month
June 27, 2025
Healthy Living: How One Team Member Used a “Tough” Challenge as Motivation for Staying in Shape
June 27, 2025
Exact's Healthy Living: Antioxidant Smoothie Recipe
June 19, 2025
Exact Sciences Completes Enrollment of DeeP-C Clinical Trial for Colorectal Cancer Screening
June 18, 2025
New Noninvasive Colorectal Cancer Test Shows Promise
May 22, 2025
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
April 29, 2025
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
April 14, 2025
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
March 31, 2025
Exact Sciences Launches the CologuardTM Plus Test, Transforming Colorectal Cancer Screening
February 19, 2025
Exact Sciences Announces Fourth Quarter 2024 Results
February 5, 2025
Flatiron Health and Exact Sciences Partner to Advance Clinical Evidence Generation for Molecular Residual Disease Testing
January 21, 2025
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
January 21, 2025
New Evidence Validates Oncodetect’sTM Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
January 13, 2025
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
2024
December 2, 2024
Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening
November 25, 2024
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
November 18, 2024
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community
November 13, 2024
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
November 5, 2024
Exact Sciences Announces Third-Quarter 2024 Results
October 27, 2024
Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
October 4, 2024
FDA Approves Exact Sciences’ Cologuard PlusTM Test, Setting A New Benchmark in Non-Invasive Colorectal Cancer Screening
September 16, 2024
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
August 20, 2024
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
July 31, 2024
EXACT SCIENCES ANNOUNCES SECOND-QUARTER 2024 RESULTS
July 17, 2024
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
April 4, 2024
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to inform treatment
March 13, 2024
The New England Journal of Medicine Publishes Cologuard PlusTM Test Results from Pivotal BLUE-C Study
March 7, 2024
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to have a game plan against colon cancer
February 21, 2024
Exact Sciences Announces Fourth Quarter 2023 Results
2023
December 8, 2023
DAK PRESCOTT JOINS RYAN REYNOLDS’ MAXIMUM EFFORT AND THE COLORECTAL CANCER ALLIANCE TO 'LEAD FROM BEHIND'
December 7, 2023
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
November 20, 2023
Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO® 2023
November 17, 2023
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
November 1, 2023
Exact Sciences Announces Third-Quarter 2023 Results
October 21, 2023
Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
October 9, 2023
Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023
September 12, 2023
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
August 30, 2023
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical TRIALs
August 21, 2023
Not a Wall But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings
August 1, 2023
Exact Sciences Announces Second-Quarter 2023 Results
June 21, 2023
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
May 17, 2023
Exact Sciences Awards Grants To 18 Organizations Focused On Increasing Colorectal Cancer Screenings
April 12, 2023
EXACT SCIENCES PRESENTS ADVANCEMENTS IN CANCER DETECTION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH® 2023 ANNUAL MEETING
February 21, 2023
Exact Sciences Announces Fourth Quarter 2022 Results
2022
December 9, 2022
Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
December 6, 2022
Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022
November 3, 2022
Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
September 22, 2022
Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations
September 10, 2022
Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress
August 2, 2022
Exact Sciences Announces Second Quarter 2022 Results
May 19, 2022
Exact Sciences at DDW 2022
March 7, 2022
Katie Couric and Cologuard Team Up to Spread Awareness and Urgency for People to Get Screened for Colon Cancer
January 10, 2022
Exact Sciences Announces Preliminary Fourth Quarter 2021 Results
2021
December 8, 2021
New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making
November 23, 2021
New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as Predictor of Prostate Cancer Outcomes in Clinically Low-Risk Patients
November 18, 2021
Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection
October 27, 2021
New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening
September 3, 2021
Exact Sciences to Present New Oncotype DX Genomic Prostate Score® Test Data and Exhibit its Full Urology Portfolio at the 2021 Virtual AUA Annual Meeting
August 13, 2021
Published Data Shows OncoguardTM Liver Delivers Enhanced Performance for Early-stage Detection of HCC
March 17, 2021
JAMIE FOXX, STAND UP TO CANCER AND EXACT SCIENCES LAUNCH PSA TO INCREASE AWARENESS OF COLORECTAL CANCER
February 10, 2021
The Truth About Cancer: Debunking Five Myths about the Big C
2020
December 17, 2020
$10 MILLION GRANT FROM EXACT SCIENCES TO SUPPORT STAND UP TO CANCER INITIATIVE TO IMPROVE COLORECTAL CANCER SCREENING AND PREVENTION
December 11, 2020
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
December 11, 2020
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
November 2, 2020
Exact Sciences Mourns the Death of Dr. David Ahlquist, a Pioneer in Early Cancer Detection
October 28, 2020
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
October 12, 2020
Exact Sciences Introduces the Oncotype MAPTM Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer
March 15, 2020
Message from Chairman & CEO, Kevin Conroy
2019
December 5, 2019
Dr. David Ahlquist, Co-Inventor of Cologuard, Named a Fellow of the National Academy of Inventors
November 8, 2019
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company
November 8, 2019
Exact Sciences Presents Data on Blood-based Test for Detection of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation
October 29, 2019
Exact Sciences Presents New Stool-based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study
September 24, 2019
PGA Tour Champions and Exact Sciences Announce Five-year Extension of Cologuard Classic
September 19, 2019
Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work and Fortune
September 10, 2019
Cologuard® Helps More People Get Screened In A Cost-Effective Way
July 29, 2019
Exact Sciences And Genomic Health To Combine, Creating Leading Global Cancer Diagnostics Company
March 19, 2019
Kathleen Sebelius Appointed to Exact Sciences Board
February 27, 2019
Cologuard Helps Screen Two Million People for Colorectal Cancer
2018
August 15, 2018
University Research Park Breaks Ground on Corporate Headquarters Building for Exact Sciences
June 26, 2018
Nurse Practitioners are Critical Source of Colorectal Cancer Screening Information for Patients, Survey Shows
June 5, 2018
Pipeline Update: Promising Advances in Early Liver Cancer Detection Shared at International Conference
April 26, 2018
Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000
January 11, 2018
Investing in our Long-Term Growth
2017
December 27, 2017
Urban League and Exact Sciences Partnership
December 8, 2017
Cologuard's Impact on NCCRT's 80% by 2018 Call to Action
November 20, 2017
For the Second Consecutive Year, Exact Sciences included in Deloitte’s Technology Fast 500.
November 15, 2017
Cologuard's Patient Compliance Program
November 7, 2017
PGA TOUR Champions and Exact Sciences announce Cologuard Classic as new title of Tucson event
October 30, 2017
Expansion through the Third Quarter
August 2, 2017
Continued Momentum Through the Second Quarter
May 1, 2017
A Strong Start to 2017
February 28, 2017
Highlighting our Mission in March
February 21, 2017
Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase
January 18, 2017
Cologuard Increases Patient Compliance
January 12, 2017
Using the Cologuard Platform to Take on Other Cancers
January 10, 2017
More Than Just Numbers
2016
December 21, 2016
Exact Sciences Joins Deloitte’s Technology Fast 500 as One of the Sector’s Fastest Growing Companies
November 8, 2016
Exact Sciences Appoints Jeff Elliott Chief Financial Officer
October 28, 2016
Exact Sciences' Cologuard Wins Prestigious Prix Galien Award for Best Medical Technology Product
October 3, 2016
What Cologuard's Inclusion in HEDIS Means
August 15, 2016
CMS Affirms Cologuard® Covered Every Three Years for Medicare Advantage Beneficiaries Without Cost Sharing
June 20, 2016
A Letter To Our Shareholders
June 15, 2016
Exact Sciences' Cologuard Included in Final USPSTF Colorectal Cancer Screening Recommendations
March 22, 2016
#YourScreeningTeam: Meet The People Behind Cologuard
March 15, 2016
Highlights from our South by Southwest Appearance
March 3, 2016
AMITA Health Adopts Cologuard
February 25, 2016
Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service
February 24, 2016
Exact Sciences Reports Fourth Quarter and Full Year 2015 Results
February 23, 2016
Modeling Data Supports Cologuard Use Every Three Years
January 25, 2016
Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors
January 11, 2016
New Modeling Supports Using Cologuard® Every Three Years
2015
December 17, 2015
Exact Sciences Names John Bakewell Chief Financial Officer
December 1, 2015
Managing A World-Class Laboratory: A Q&A With Our Director of Clinical Laboratory Operations
November 4, 2015
Exact Sciences to Participate in November Investor Conferences
November 2, 2015
Exact Sciences Aims to Collaborate with City of Madison & University of Wisconsin in Developing a Biotech Campus
October 29, 2015
View Slides from our Third quarter 2015 earnings call
October 29, 2015
Cologuard(R) Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015
October 28, 2015
New Study Bolsters Cologuard's Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening
October 19, 2015
A Closer Look At The sDNA Posters Featured at ACG 2015
October 19, 2015
Stool DNA Screening Technology to be Featured at ACG 2015
October 15, 2015
Building The Exact Sciences Team: An Interview with HR Business Manager Samantha Michalski
October 6, 2015
View Webcast Archive and Slides from Exact Sciences' Conference Call Regarding USPSTF Draft Recommendations
September 25, 2015
Exact Sciences to Participate in Economist's Health Care Forum
August 31, 2015
Exact Sciences to Participate in Baird Healthcare Conference
August 26, 2015
Exact Sciences Highlights CMS Advisory Panel's Unanimous Vote to Maintain Medicare Reimbursement Rate for Cologuard®
August 19, 2015
Exact Sciences Wins Wisconsin Innovation Award
August 18, 2015
Driven By the Mission: How Toby Vaughn Joined and Helped Build Our Clinical Operations Department
August 11, 2015
Cologuard: One Year Later
August 4, 2015
Exact Sciences to Participate in August Conferences
July 23, 2015
View and Download 2015 Shareholder Meeting Slides
July 20, 2015
Exact Sciences Highlights Cologuard's® Positive Launch Trajectory in Second Quarter 2015
July 7, 2015
Investor & Analyst Day At-A-Glance
June 19, 2015
#EXASIRDay: Meet The Exact Sciences Leadership Team
June 17, 2015
Ask Our Management Team A Question For #EXASIRDay
June 16, 2015
Exact Sciences to Webcast Investor & Analyst Day
May 18, 2015
Employee Q&A: What It Takes To Get Results
May 15, 2015
Exact Sciences’ Stool DNA Screening Technology Featured in Posters at Digestive Disease Week 2015
May 15, 2015
Wisconsin Chamber Orchestra Announces Exact Sciences as Exclusive Sponsor of 2015 Concerts on the Square
May 8, 2015
Exact Sciences Announces Contract With Largest Insurer in Rhode Island to Cover Cologuard®
April 29, 2015
Exact Sciences to Participate in May Conferences
March 9, 2015
Exact Sciences and Ironwood Pharmaceuticals Enter Co-Promotion Agreement for Cologuard®
February 23, 2015
Exact Sciences Awarded $9 Million in Tax Credits from WEDC
February 6, 2015
Exact Sciences and Mayo Clinic Extend, Expand Collaboration to Continue Fighting Cancer through Advanced Screening
February 2, 2015
Exact Sciences’ Growth Leads Wisconsin State Journal
January 30, 2015
Cologuard® Blitzes the Marketplace at J.P. Morgan
January 29, 2015
Exact Sciences Announces Norton Healthcare to Adopt Cologuard
January 13, 2015
Cologuard® Wins Everyday Health Award For Innovation
2014
November 6, 2014
Cologuard Included in American Cancer Society Colorectal Cancer Prevention and Early Detection Guidelines
August 12, 2014
FDA Approves Exact Sciences’ Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
August 12, 2014
FDA Approves Exact Sciences’ Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test